共 83 条
[3]
Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
[J].
METABOLISM-CLINICAL AND EXPERIMENTAL,
2016, 65 (08)
:1080-1086
[4]
mTOR, AMPK, and Sirt1: Key Players in Metabolic Stress Management
[J].
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION,
2015, 25 (01)
:59-75
[5]
Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD)
[J].
NUTRIENTS,
2017, 9 (02)
[6]
Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity
[J].
REDOX BIOLOGY,
2019, 21
[7]
Chen Z, 2020, FREE RADICAL BIO MED, V152, P116, DOI 10.1016/j.freeradbiomed.2020.02.025
[9]
SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease
[J].
MEDICAL SCIENCE MONITOR,
2011, 17 (05)
:HY5-HY9
[10]
Emerging roles of SIRT1 in fatty liver diseases
[J].
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES,
2017, 13 (07)
:852-867